医学综述
醫學綜述
의학종술
MEDICAL RECAPITULATE
2015年
3期
536-538
,共3页
崔艳敏%孙璐%王淑敏%刘倩
崔豔敏%孫璐%王淑敏%劉倩
최염민%손로%왕숙민%류천
二甲双胍%糖尿病,2型%C反应蛋白%瑞舒伐他汀
二甲雙胍%糖尿病,2型%C反應蛋白%瑞舒伐他汀
이갑쌍고%당뇨병,2형%C반응단백%서서벌타정
Metformin%Diabetes mellitus,type 2%C-reactive protein%Rosuvastatin
目的:探讨二甲双胍结合瑞舒伐他汀联合用药治疗初诊肥胖型2型糖尿病患者高敏C反应蛋白( hs-CRP)水平的影响。方法将2011年6月至2013年7月于河北省保定市第四医院就诊的212例初诊肥胖型2型糖尿病患者依据随机数字表法按就诊顺序分治疗组( n =106,二甲双胍联合瑞舒伐他汀治疗)和对照组( n=106,单纯应用二甲双胍治疗)。疗程12周。治疗结束后,检测两组患者治疗前后体质量指数、血糖、血脂、HOMA-IR指数和 hs-CRP。结果治疗后,两组患者的空腹血糖、餐后血糖、糖化血红蛋白、三酰甘油、总胆固醇、低密度脂蛋白、hs-CRP、体质量指数、HOMA-IR均低于治疗前,且治疗组低于对照组,差异有统计学意义( P<0.01)。结论初诊肥胖型2型糖尿病患者采用二甲双胍联合瑞舒伐他汀疗法疗效理想,在控制血糖的基础上,能够有效降低患者的血脂和hs-CRP水平,改善胰岛素抵抗,对预防糖尿病大血管并发症有积极作用。
目的:探討二甲雙胍結閤瑞舒伐他汀聯閤用藥治療初診肥胖型2型糖尿病患者高敏C反應蛋白( hs-CRP)水平的影響。方法將2011年6月至2013年7月于河北省保定市第四醫院就診的212例初診肥胖型2型糖尿病患者依據隨機數字錶法按就診順序分治療組( n =106,二甲雙胍聯閤瑞舒伐他汀治療)和對照組( n=106,單純應用二甲雙胍治療)。療程12週。治療結束後,檢測兩組患者治療前後體質量指數、血糖、血脂、HOMA-IR指數和 hs-CRP。結果治療後,兩組患者的空腹血糖、餐後血糖、糖化血紅蛋白、三酰甘油、總膽固醇、低密度脂蛋白、hs-CRP、體質量指數、HOMA-IR均低于治療前,且治療組低于對照組,差異有統計學意義( P<0.01)。結論初診肥胖型2型糖尿病患者採用二甲雙胍聯閤瑞舒伐他汀療法療效理想,在控製血糖的基礎上,能夠有效降低患者的血脂和hs-CRP水平,改善胰島素牴抗,對預防糖尿病大血管併髮癥有積極作用。
목적:탐토이갑쌍고결합서서벌타정연합용약치료초진비반형2형당뇨병환자고민C반응단백( hs-CRP)수평적영향。방법장2011년6월지2013년7월우하북성보정시제사의원취진적212례초진비반형2형당뇨병환자의거수궤수자표법안취진순서분치료조( n =106,이갑쌍고연합서서벌타정치료)화대조조( n=106,단순응용이갑쌍고치료)。료정12주。치료결속후,검측량조환자치료전후체질량지수、혈당、혈지、HOMA-IR지수화 hs-CRP。결과치료후,량조환자적공복혈당、찬후혈당、당화혈홍단백、삼선감유、총담고순、저밀도지단백、hs-CRP、체질량지수、HOMA-IR균저우치료전,차치료조저우대조조,차이유통계학의의( P<0.01)。결론초진비반형2형당뇨병환자채용이갑쌍고연합서서벌타정요법료효이상,재공제혈당적기출상,능구유효강저환자적혈지화hs-CRP수평,개선이도소저항,대예방당뇨병대혈관병발증유적겁작용。
Objective To investigate the combination of rosuvastatin metformin combination therapy af-fect the level of newly diagnosed type 2 diabetes in obese patients with high-sensitivity C-reactive protein ( hs-CRP) ( read) .Methods June 2011 to July 2013 in Baoding, Hebei Province, the fourth hospital 212 patients with newly diagnosed obese patients with type 2 diabetes treatment order stochastic ( random in what way?) Divided into treatment group (n=106, metformin rosuvastatin therapy) and control group (n=106, the simple application of metformin).The course of treatment was 12 weeks.Blood glucose, blood lipid, BMI HOMA-IR index, hs-CRP level were detected before and after treatment.Results After treatment, fasting blood glucose, blood glucose after meal of two groups of patients, glycosylated hemoglobin, triglycer-ide, total cholesterol, three low density lipoprotein, hs-CRP, body mass index, HOMA-IR were lower than that before treatment, and the treatment group than in the control group, the difference was statistically sig-nificant (P<0.01).Conclusion Combined therapy seems efficiency in patients with newly diagnosed o-besity type 2 diabetes, it reduced the level of serum lipid levels and level of hs-CRP on the base of blood glu-cose controlling, improved insulin resistance, and had a positive effect on prevention of diabetic vascular complication.